Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To provide ongoing treatment with AMG 706 monotherapy for those subjects who have completed the planned duration of treatment with AMG 706 on a separate Amgen protocol and demonstrate continuing clinical benefit from AMG 706 therapy. To provide ongoing treatment with AMG 706 for subjects who were not eligible to remain on a separate Amgen protocol for reasons other than AMG 706 intolerance, but continue to experience clinical benefit.
Critère d'inclusion
- Dependent on the previous Amgen protocol the patient has left